CNS Response, Inc. (OTCBB: CNSO) announced that the company will present top-line results from its multi-site clinical trial next week at the U.S. Psychiatric and Mental Health Congress. “Referenced-EEG (rEEG®) Efficacy Compared to Star*D for Patients with Depression Treatment Failure: First Look at Final Results,” will be presented by Charles DeBattista, M.D. on Monday, November 2nd, at 3:45 to 6:45 p.m.
Popularity: unranked [?]
Related posts:
- Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
- Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress
- STAR*D, A Landmark Depression Study Releases Results
- STAR*D, A Landmark Depression Study Releases Results
- New Melatonergic Antidepressant Combines Efficacy With Very Favourable Side-Effect Profile
Comments
No Responses to “Landmark Results From Depression Efficacy Study To Be Presented By CNS Response At U.S. Psychiatric And Mental Health Congress”